Goal: To develop a computationally efficient and unbiased synthetic data generator for large-scale in silico clinical trials (CTs). Methods: We propose the BGMM-OCE, an extension of the conventional BGMM (Bayesian Gaussian Mixture Models) algorithm to provide unbiased estimations regarding the optimal number of Gaussian components and yield high-quality, large-scale synthetic data at reduced computational complexity. Spectral clustering with efficient eigenvalue decomposition is applied to estimate the hyperparameters of the generator. A case study is conducted to compare the performance of BGMM-OCE against four straightforward synthetic data generators for in silico CTs in hypertrophic cardiomyopathy (HCM). Conclusions: BGMM-OCE overcomes the lack of population size in HCM which obscures the development of targeted therapies and robust risk stratification models.

Bayesian Inference-Based Gaussian Mixture Models with Optimal Components Estimation Towards Large-Scale Synthetic Data Generation for in Silico Clinical Trials / Pezoulas V.C., Tachos N.S., Gkois G., Olivotto I., Barlocco F., Fotiadis D.I.. - In: IEEE OPEN JOURNAL OF ENGINEERING IN MEDICINE AND BIOLOGY. - ISSN 2644-1276. - ELETTRONICO. - 3:(2022), pp. 108-114. [10.1109/OJEMB.2022.3181796]

Bayesian Inference-Based Gaussian Mixture Models with Optimal Components Estimation Towards Large-Scale Synthetic Data Generation for in Silico Clinical Trials

Olivotto I.;Barlocco F.;
2022

Abstract

Goal: To develop a computationally efficient and unbiased synthetic data generator for large-scale in silico clinical trials (CTs). Methods: We propose the BGMM-OCE, an extension of the conventional BGMM (Bayesian Gaussian Mixture Models) algorithm to provide unbiased estimations regarding the optimal number of Gaussian components and yield high-quality, large-scale synthetic data at reduced computational complexity. Spectral clustering with efficient eigenvalue decomposition is applied to estimate the hyperparameters of the generator. A case study is conducted to compare the performance of BGMM-OCE against four straightforward synthetic data generators for in silico CTs in hypertrophic cardiomyopathy (HCM). Conclusions: BGMM-OCE overcomes the lack of population size in HCM which obscures the development of targeted therapies and robust risk stratification models.
2022
3
108
114
Goal 3: Good health and well-being
Pezoulas V.C.; Tachos N.S.; Gkois G.; Olivotto I.; Barlocco F.; Fotiadis D.I.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1499597
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 14
  • ???jsp.display-item.citation.isi??? 9
social impact